AlphAIalphai — Financial news for AI agents
SEC EDGARAUG 251 min read$MMSI

Peterson Neil W. sold $678K of MMSI

Peterson Neil W. (CHIEF OPERATING OFFICER) sold 7,500 shares of MERIT MEDICAL SYSTEMS INC (MMSI) at $90.45 ($0.68M total) on 2026-08-24.

Original reporting
SEC EDGAR · Peterson Neil W.
Published Aug 25, 2026, 8:43 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 25, 2026, 8:56 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About alphai AI DeskScoring methodologyReport an issue
alphai market briefInsider activity
Primary signal
$MMSI
Neutral
medium confidence
Mentioned
$MMSI
Relevance
5/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$MMSINeutralLow
01

Why it matters

The sale reduces insider ownership but is not large enough to move the stock significantly.

02

Market read

Insider sale provides a data point for investors but likely limited price impact.

03

What to watch

Potential upcoming corporate actions or compensation plans not disclosed.

Relevance 5/10Novelty 6/10Timing: post-market 2026-08-24

Background

Form 4 filings disclose insider transactions; traders monitor them for signals.

Company-level read

Ticker impact

$MMSINeutralMedium confidence
Context

COO Peterson Neil W. sold 7,500 shares for $678,360, lowering his stake to 18,051 shares.

Expected impact

Potential modest downward pressure on MMSI price.

Evidence & confidence

Officer sale of ~0.4% of float, modest size, typical for diversification.

Market effects

Sector

Minimal impact on medical device sector; similar insider sales are common.

Regional

No regional effect.

Global

Limited to investors tracking insider activity.

Counterpoint

What could challenge this read

Sale could be routine liquidity need, not a negative signal.

Key entities

  • Company
    Merit Medical Systems Inc.

    Medical device manufacturer listed on NASDAQ (MMSI).

  • Person
    Peterson Neil W.

    Chief Operating Officer of Merit Medical Systems.

Read at source← All news

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

MMSI insider trading history →

Related articles

AUG 12
$MMSIMedAI 8/10

Merit Medical Systems (MMSI) Is Up 6.2% After Raising 2026 Outlook And Q2 Beat Expectations – Has The Bull Case Changed?

Merit Medical Systems (MMSI) reported Q2 2026 sales of $418.84 million and net income of $38.8 million, and raised its full-year 2026 revenue outlook to $1.63 billion to $1.64 billion, according to the company. The article notes ongoing product recalls and reimbursement risks and mentions a 2029 narrative of about $1.8 billion revenue and $213.7 million earnings.

simplywall.st6 min
AUG 9
$MMSIMedAI 8/10

Merit Medical (MMSI) Q2 2026 Earnings Call Transcript

Merit Medical Systems (MMSI) reported Q2 2026 revenue of $418.8 million, up 10% GAAP, and non-GAAP EPS of $1.19. Non-GAAP operating margin was 22.6% and free cash flow $51.9 million. The company raised 2026 revenue guidance to $1.631B-$1.643B and non-GAAP EPS to $4.25-$4.35, and guided Q3 revenue to $408M-$413M.

aol.com6 min
AUG 8
$MMSIMedAI 8/10

Merit Medical (MMSI) Q2 2026 Earnings Call Transcript

Merit Medical Systems (MMSI) reported Q2 2026 revenue of $418.8 million, up 10% GAAP, and non-GAAP EPS of $1.19. Non-GAAP operating margin was 22.6% and free cash flow $51.9 million. The company raised 2026 revenue guidance to $1.631B-$1.643B and non-GAAP EPS to $4.25-$4.35, and guided Q3 revenue to $408M-$413M.

fool.com6 min
JUL 31
$MMSIMedAI 8/10

These Analysts Increase Their Forecasts On Merit Medical Systems After Strong Q2 Results - Merit Medical

Merit Medical Systems Inc (NASDAQ:MMSI) posted better-than-expected earnings for the second quarter on Thursday. The company posted adjusted EPS of $1.19, beating market estimates of 96 cents per share. The company’s sales came in at $418.843 million versus expectations of $405.268 million. Merit Medical Systems raised its FY2026 adjusted EPS guidance from $4.01-$4.15 to $4.25-$4.35 and increased its sales forecast from $1.612 billion-$1.634 billion to $1.631 billion-$1.643 billion.

benzinga.com3 min
JUL 30
$MMSIMedAI 8/10

Merit Medical Systems (NASDAQ:MMSI) Reports Bullish Q2 CY2026, Stock Soars

Medical device company Merit Medical Systems (NASDAQ: MMSI) reported Q2 CY2026 results beating Wall Street’s revenue expectations, with sales up 9.5% year on year to $418.8 million. The company’s full-year revenue guidance of $1.64 billion at the midpoint came in 1.1% above analysts’ estimates. Its non-GAAP profit of $1.19 per share was 24% above analysts’ consensus estimates. Is now the time to buy Merit Medical Systems? Find out by accessing our full research report, it’s free.

financialcontent.com4 min